MoneyWorks4Me

Alembic Pharmaceuticals board to consider unaudited financial results

13 Oct 2015 Evaluate

Alembic Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on October 27, 2015, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on September 30, 2015 (Q2). Further, the trading window shall remain closed from October 24, 2015 to October 29, 2015 for the above purpose.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..